ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
16/06/2023
Voltar para busca
Dado oficial do USPTO
NUCLERA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
NUCLERA
ST13
US500000079294807Classe
1, 5, 9, 10, 40, 42, 44
Pedido
79294807
Registro
6624194
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
16/06/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10, 40, 42, 44
Data de depósito
19/11/2019
Data de registro
25/01/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/01/2022
Última transação
21/04/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
CHHINA, KARANENDRA S
Unidade examinadora
M50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Nuclera Ltd
Nuclera Nucleics Ltd
Representantes
Rebecca Liebowitz Venable LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10Classe 40Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for scientific purposes; chemicals for use in research; chemicalsenzymesDNA and RNA for research use; chemicals for use in the preparation and creation of DNA and RNA; enzymes for use in the preparation and creation of DNA and RNA; molecular biology research tools in the nature of biological and biochemical reagents; gene editing enzymes
Classe 5
Biologicalchemical and biochemical reagentsDNA and RNA productsproteins and gene editing enzymes for clinical or medical laboratory use; pharmaceutical and veterinary preparationsnucleic acids comprising natural and synthetic nucleotides and oligonucleotides for medical and veterinary purposes; therapeutic DNA and RNAnucleic acid sequences and chemical reagents for medical and veterinary purposes
Classe 9
Scientific research and laboratory apparatusscientific desktop instruments for geneRNA and protein synthesis; semiconductorssemiconductor chipsmicrochipsbio-sensorsbio-chips; scientific research and laboratory apparatusapparatus for amplifying DNA and RNAapparatus for manufacturing DNA and RNAapparatus for processing DNA and RNA; apparatus for recordingtransmission or reproduction of data including videoaudioimages and text for scientific purposes; data processing equipment and computers; computer hardware; downloadable and recorded computer software for scientific data analysis; downloadable and recorded computer programs for scientific data analysis; data carriers containing scientific data; parts and fittings for all the aforesaid goods
Classe 10
Medical and veterinary apparatus and instruments namelyapparatus for DNA and RNA analysissequencing and synthesis; apparatus for geneRNA and protein synthesis for medical and veterinary purposes
Classe 40
Custom manufacture of therapeutic drugsincluding therapeutic DNARNAgenes and oligonucleotides; manufacture of synthetic DNARNAgenes and oligonucleotides for others
Classe 42
Scientific and technological servicesscientific researchstructural and functional analysis of genomes and genetic testing and in the fields of genomicsDNA and RNA sequencinggene synthesisRNA synthesisprotein synthesisgene identificationgene cloninggene expressiongene mappingresearch and design in the field of DNA research and developmentgene and protein synthesis; chemical and biological analysis and research services; research into DNA and RNA for scientific purposes; research and development into the creation of DNA and RNA; researchdevelopmentscientific testing and analysis in the field of genomicsDNA and RNA sequencinggene synthesisgene identificationgene cloninggene expressiongene mapping; scientific research in the field of molecular biologynext generation sequencinghigh-throughput sequencing and bioinformatics; gene-editing services for scientific research purposes; DNA and RNA modelling services for scientific purposes; gene engineering services; research and development services in the creation of genome libraries or collections of biologicals including chemicals and compounds; creating libraries or collections of normal and mutated genes for scientific research purposes; electronic data storage services; consultancy and advisory services relating to the aforesaid services
Classe 44
Medical and veterinary services; healthcare services; DNA and RNA screening for medical purposes; genetic and blood testingsequencing and measuring services for medical and health purposes; provision of information relating to the analysis of DNA and RNA for medical and health purposes; providing advice and consultancy in the field of medical and veterinary therapies
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
25/07/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
30/06/2022
FIMP
FINAL DISPOSITION PROCESSED
29/06/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
25/04/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
25/01/2022
CHPB
POST PUBLICATION AMENDMENT - ENTERED
17/12/2021
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
16/12/2021
APET
ASSIGNED TO PETITION STAFF
16/12/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
01/12/2021
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
29/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/06/2021
PUBO
PUBLISHED FOR OPPOSITION
08/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/05/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/05/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
04/05/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/05/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
04/05/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/05/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/04/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/04/2021
RFNT
REFUSAL PROCESSED BY IB
22/11/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/11/2020
RFRR
REFUSAL PROCESSED BY MPU
03/11/2020
MAFR
APPLICATION FILING RECEIPT MAILED
10/10/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/10/2020
CNRT
NON-FINAL ACTION WRITTEN
08/10/2020
DOCK
ASSIGNED TO EXAMINER
06/10/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/10/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/10/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NUCLERA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.